Adipose tissue as a buffer for daily lipid flux

被引:620
作者
Frayn, KN [1 ]
机构
[1] Univ Oxford, Oxford Lipid Metab Grp, Oxford Ctr Diabet Endocrinol & Metab, Radcliffe Infirm, Oxford OX2 6HE, England
关键词
adipose tissue; insulin resistance; obesity; lipodystrophy; fatty acids;
D O I
10.1007/s00125-002-0873-y
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Insulin resistance occurs in obesity and Type II (non-insulin-dependent) diabetes mellitus, but it is also a prominent feature of lipodystrophy. Adipose tissue could play a crucial part in buffering the flux of fatty acids in the circulation in the postprandial period, analogous to the roles of the liver and skeletal muscle in buffering postprandial glucose fluxes. Adipose tissue provides its buffering action by suppressing the release of non-esterified fatty acids into the circulation and by increasing triacylglycerol clearance. In particular, the pathway of 'fatty acid trapping' (adipocyte uptake of fatty acids liberated from plasma triacylglycerol by lipoprotein lipase) could play a key part in the buffering process. If this buffering action is impaired, then extra-adipose tissues are exposed to excessive fluxes of lipid fuels and could accumulate these in the form of triacylglycerol, leading to insulin resistance. These tissues will include liver, skeletal muscle and the pancreatic beta cell, where the long term effect is to impair insulin secretion. Adipose tissue buffering of lipid fluxes is impaired in obesity through defects in the ability of adipose tissue to respond rapidly to the dynamic situation that occurs after meals. It is also impaired in lipodystrophy because there is not sufficient adipose tissue to provide the necessary buffering capacity. Thus, the phenotype, at least with regard to insulin resistance, is similar with both excess and deficiency of adipose tissue. Furthermore, this concept could provide a framework for understanding the action of the thiazolidinedione insulin-sensitizing agents.
引用
收藏
页码:1201 / 1210
页数:10
相关论文
共 116 条
[1]
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[3]
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[4]
Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? [J].
Bergman, RN .
DIABETOLOGIA, 2000, 43 (07) :946-+
[5]
Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols [J].
Binnert, C ;
Pachiaudi, C ;
Beylot, M ;
Hans, D ;
Vandermander, J ;
Chantre, P ;
Riou, JP ;
Laville, M .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 67 (04) :595-601
[6]
BJORNTORP P, 1995, INT J OBESITY, V19, P839
[7]
Bjorntorp Per, 1994, Current Opinion in Lipidology, V5, P166, DOI 10.1097/00041433-199405030-00003
[8]
RELATIONSHIP BETWEEN DEGREE OF OBESITY AND INVIVO INSULIN ACTION IN MAN [J].
BOGARDUS, C ;
LILLIOJA, S ;
MOTT, DM ;
HOLLENBECK, C ;
REAVEN, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (03) :E286-E291
[9]
FAT-METABOLISM IN HUMAN OBESITY [J].
CAMPBELL, PJ ;
CARLSON, MG ;
NURJHAN, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :E600-E605
[10]
Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy [J].
Chen, GX ;
Koyama, K ;
Yuan, X ;
Lee, Y ;
Zhou, YT ;
ODoherty, R ;
Newgard, CB ;
Unger, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14795-14799